2009
DOI: 10.2174/1876386300902010024
|View full text |Cite
|
Sign up to set email alerts
|

C-fiber-Selective Peripheral Nerve Blockade

Abstract: Despite the clinical demand, current uses of local anesthetics do not allow selective blockade of nociceptive fibers. Regional anesthesia produces an analgesic effect accompanied with undesired side effects due to block of motor, non-nociceptive sensory and autonomic fibers. These side effects limit the clinical use of local anesthetics and affect the recovery and rehabilitation period after surgical procedures. Therefore one main goal of research in the field of regional anesthesia is selectively targeting no… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
6
0
3

Year Published

2009
2009
2018
2018

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 72 publications
0
6
0
3
Order By: Relevance
“…Presumably, the possible contributing factors for this contrasting finding might be the differences between the nerves being blocked, neuraxial versus peripheral nerves 27 ; the doses of DEX; and the volumes and types of local anesthetics used in the respective blocks where the bupivacaine is reported to produce longer motor blockade compared with ropivacaine. [28][29][30] As the dose of IV DEX increases, systemic effects such as prolonged sedation 10 and safety concerns of hemodynamic instabilities should be raised. 31 Dexmedetomidine has dose-dependent sedative effects, 24 but it usually resolves within 2 hours after terminating the infusion.…”
Section: Discussionmentioning
confidence: 99%
“…Presumably, the possible contributing factors for this contrasting finding might be the differences between the nerves being blocked, neuraxial versus peripheral nerves 27 ; the doses of DEX; and the volumes and types of local anesthetics used in the respective blocks where the bupivacaine is reported to produce longer motor blockade compared with ropivacaine. [28][29][30] As the dose of IV DEX increases, systemic effects such as prolonged sedation 10 and safety concerns of hemodynamic instabilities should be raised. 31 Dexmedetomidine has dose-dependent sedative effects, 24 but it usually resolves within 2 hours after terminating the infusion.…”
Section: Discussionmentioning
confidence: 99%
“…TRPV1 agonists induce desensitization and inactivation of nociceptive neurons, impeding these neurons to respond to a subsequent stimulus [ 28 ]. Recent studies have shown that activation of TRPV1 with capsaicin or lidocaine can selectivity deliver a quaternary local anesthetic QX-314 to target only nociceptive fibers for a sustained blockade [ 26 , 30 ]. However the duration of this specific blockade (<12 h) may not be long enough for the purpose of the present study.…”
Section: Discussionmentioning
confidence: 99%
“…Long-term and selective blockade of nociceptive fibers is attractive and can be achieved using the sodium channel blocker QX-314 combined with capsaicin [ 26 ] or resiniferatoxin (RTX), an ultrapotent agonist for transient receptor potential vanilloid subtype-1 (TRPV1) that is only expressed in nociceptors [ 27 , 28 ]. Nociceptive-specific block can provide analgesia without affecting motor function or pain-unrelated sensory function [ 29 , 30 ]. Recently electrical stimulation at C-fiber intensity has been shown to induce microglial changes [ 31 ], but it is unclear whether blocking nociceptive fibers alone would suppress spinal microglial activation after nerve injury.…”
Section: Introductionmentioning
confidence: 99%
“…One strategy is to deliver a permanently charged sodium channel blocker such as QX-314 ( N -ethyl-lidocaine) by entry through large-pore ion channels selectively expressed in nociceptive neurons [33]. The transient receptor potential vanilloid 1 (TRPV1) channel is a primary nociceptive transducer in pain-sensing neurons, activated by noxious heat (>43 °C), capsaicin, protons and endocannabinoids [8,36].…”
Section: Introductionmentioning
confidence: 99%